You are viewing the site in preview mode

Skip to main content

Table 3 Prevalence of hypercholesterolemia diagnosis based on the NCEP ATP III guidelines across demographic variables

From: Evaluation of the hypercholesterolemia care cascade and compliance with NCEP-ATP III guidelines in Iran based on the WHO STEPS survey

Variable

Group

Prevalence (%)

95% CI (%)

P_value

Age Group

25–29

46.15

42.26 – 50.04

 < 0.001

30–34

53.63

50.32 – 56.94

35–39

51.12

48.44 – 53.81

40–44

53.05

50.22 – 55.88

45–49

54.76

51.74 – 57.78

50–54

55.64

52.68 – 58.61

55–59

61.2

58.22 – 64.19

60–64

59.91

55.83 – 63.99

65 and above

60.75

58.29 – 63.21

Sex

Male

66.73

65.33 – 68.21

 < 0.001

Female

46.56

45.19 – 47.93

Area

Rural

53.04

51.51 – 54.57

0.001

Urban

56.31

55.00 – 57.63

Education Level

0 Years

57.85

55.44 – 60.26

0.03

1–7 Years

56.13

53.74 – 58.52

7–12 Years

55.68

53.56 – 57.80

 > 12 Years

53.68

51.50 – 55.86

Wealth Index

Poorest (1)

54.1

51.85 – 56.35

0.74

Second (2)

55.67

53.38 – 57.95

Middle (3)

56.13

54.04 – 58.21

Fourth (4)

55.66

53.45 – 57.87

Richest (5)

56.16

53.40 – 58.92